These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8895539)
21. Simultaneous chromosome 7 and 17 gain and sex chromosome loss provide evidence that renal metanephric adenoma is related to papillary renal cell carcinoma. Brown JA; Anderl KL; Borell TJ; Qian J; Bostwick DG; Jenkins RB J Urol; 1997 Aug; 158(2):370-4. PubMed ID: 9224305 [TBL] [Abstract][Full Text] [Related]
22. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p. Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014 [TBL] [Abstract][Full Text] [Related]
23. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas. Kovacs A; Storkel S; Thoenes W; Kovacs G J Pathol; 1992 Jul; 167(3):273-7. PubMed ID: 1381433 [TBL] [Abstract][Full Text] [Related]
24. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease. Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029 [TBL] [Abstract][Full Text] [Related]
25. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations. Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097 [TBL] [Abstract][Full Text] [Related]
26. Genetic alterations in renal cell carcinoma with rhabdoid differentiation. Perrino CM; Hucthagowder V; Evenson M; Kulkarni S; Humphrey PA Hum Pathol; 2015 Jan; 46(1):9-16. PubMed ID: 25439741 [TBL] [Abstract][Full Text] [Related]
27. [Prognosis of renal cell carcinoma and detection of numerical chromosome aberration]. Uchida K; Akaza H; Nemoto R; Nakamura Y Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():313-9. PubMed ID: 9263522 [TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas. Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230 [TBL] [Abstract][Full Text] [Related]
29. Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249 [TBL] [Abstract][Full Text] [Related]
31. Chromosomal abnormalities of clear cell renal cell carcinoma: frequent gain of chromosome 7. Kuroda N; Tamura M; Shiotsu T; Nakamura S; Taguchi T; Tominaga A; Hes O; Michal M; Kawada C; Shuin T; Lee GH Pathol Int; 2010 Jan; 60(1):9-13. PubMed ID: 20055946 [TBL] [Abstract][Full Text] [Related]
32. Mutations of the p53 gene in carcinomas of the urinary system. Suzuki Y; Tamura G Acta Pathol Jpn; 1993 Dec; 43(12):745-50. PubMed ID: 8109252 [TBL] [Abstract][Full Text] [Related]
33. Fluorescent microsatellite analysis reveals duplication of specific chromosomal regions in papillary renal cell tumors. Palmedo G; Fischer J; Kovacs G Lab Invest; 1997 Dec; 77(6):633-8. PubMed ID: 9426401 [TBL] [Abstract][Full Text] [Related]
34. Interphase cytogenetics of multicentric renal cell tumours confirm associations of specific aberrations with defined cytomorphologies. Amo-Takyi BK; Mittermayer C; Günther K; Handt S Br J Cancer; 2000 Apr; 82(8):1407-14. PubMed ID: 10780519 [TBL] [Abstract][Full Text] [Related]
35. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma. Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966 [TBL] [Abstract][Full Text] [Related]
36. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffin-embedded tissue. Reid-Nicholson MD; Motiwala N; Drury SC; Peiper SC; Terris MK; Waller JL; Ramalingam P Ann Diagn Pathol; 2011 Feb; 15(1):37-45. PubMed ID: 21238914 [TBL] [Abstract][Full Text] [Related]
37. Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors. Chemeris G; Loktinov A; Rempel A; Schwarz M; Bannasch P Virchows Arch; 1995; 426(6):563-9. PubMed ID: 7655736 [TBL] [Abstract][Full Text] [Related]
38. Mutation of the VHL gene is associated exclusively with the development of non-papillary renal cell carcinomas. Kenck C; Wilhelm M; Bugert P; Staehler G; Kovacs G J Pathol; 1996 Jun; 179(2):157-61. PubMed ID: 8758207 [TBL] [Abstract][Full Text] [Related]
39. Trisomy 3 in renal cell carcinoma. Renshaw AA; Fletcher JA Mod Pathol; 1997 May; 10(5):481-4. PubMed ID: 9160314 [TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Anglard P; Tory K; Brauch H; Weiss GH; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM Cancer Res; 1991 Feb; 51(4):1071-7. PubMed ID: 1671754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]